Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy

PROPOSE: Neoadjuvant chemotherapy has been widely used in locally advanced and inflammatory breast cancer. Generally, complete pathological response after neoadjuvant chemotherapy treatment predicts survival. Studies have shown that patient-derived organoids can be used in cancer research and drug d...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Dan, Shen, Meiying, Li, Kang, Han, Xiaojian, Li, Han, Tan, Zhaofu, Wang, Yu, Peng, Yang, Tang, Zhenrong, Qu, Chi, Jin, Aishun, Liu, Shengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549797/
https://www.ncbi.nlm.nih.gov/pubmed/36194178
http://dx.doi.org/10.1080/07853890.2022.2122550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549797/
https://www.ncbi.nlm.nih.gov/pubmed/36194178
http://dx.doi.org/10.1080/07853890.2022.2122550

Ejemplares similares